
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health Inc. demonstrated robust financial performance, with gross profit reaching $269.0 million, an 8% year-over-year increase that exceeded initial estimates. Additionally, the company reported a significant growth of over 10% in its chronic therapy business, highlighting its strength in providing specialized infusion services. Furthermore, Option Care Health has raised its revenue projections for 2025 to a range of $5.5 billion to $5.65 billion, reflecting a positive outlook with a 12% year-over-year growth at the midpoint.
Bears say
The analysis of Option Care Health, Inc. indicates a negative outlook primarily due to concerns surrounding expenses and revenue stability. The potential loss of its largest customer, which accounts for 14% of its 2023 revenue, presents a significant risk to the company’s profitability. Additionally, constraints on gross margin expansion, influenced by the growth trends of lower-margin chronic therapies compared to higher-margin acute therapies, further complicate the company's outlook for future EBITDA margin improvement.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares